Pacemaker Market Scope And Analysis

  • Report Code : TIPHE100000884
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Pacemaker Market Scope, Growth, Size and Share by 2031

Buy Now

Pacemaker Market Report Pacemaker Market Size and Share Pacemaker Market Scope and Analysis

Pacemaker Market Report Scope

Report Attribute Details
Market size in 2023 US$ 7.5 billion
Market Size by 2031 US$ 15.39 billion
Global CAGR (2023 - 2031) 9.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Implantable Pacemakers
  • External Pacemakers
By Technology
  • Single Chambered
  • Dual Chambered
  • Bi-Ventricular
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medico S p A
  • Vitatron
  • Abbott
  • Medtronic
  • OSCOR
  • LivaNova Plc
  • Abiomed
  • Boston Scientific Corporation
  • Biotronik
  • Zimmer Biomet

    • Pacemaker Market News and Recent Developments

    The Pacemaker Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for neurointerventional devices and strategies:

    • Medtronic received CE (Conformité Européenne) Mark for its Micra AV2 and Micra VR2, the next generation of its industry-leading miniature, leadless pacemakers. Micra AV2 and Micra VR2, the world's smallest pacemakers, provide longer battery life and easier programming than prior Micra pacemakers, while still delivering the many benefits of leadless pacing such as reduced complications compared to traditional pacemakers. (Source: Medtronic, Company Website, 2024)
    • The U.S. Food and Drug Administration (FDA) has approved the AVEIR™ dual chamber (DR) leadless pacemaker system, manufactured by Abbott, is the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.  (Source: Abbott, Company Website, 2023)
    • MicroPort CRM received FDA approval for its latest range of implantable pacemakers, AlizeaTM and CeleaTM, the longest-lasting pacemakers for their size.  (Source: MicroPort Scientific Corporation, Company Website, 2023)

    Pacemaker Market Report Coverage and Deliverables

    The “Pacemaker Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles